| 2023-12-06 | Erasca, Inc. ERAS | Chairman & CEO | 278,150 0.1825% | $1.72 | $478,418 | +17.61% | ||
| 2023-12-05 | Erasca, Inc. ERAS | Chairman & CEO | 721,850 0.4606% | $1.69 | $1.22M | +18.34% | ||
| 2023-10-05 | Erasca, Inc. ERAS | Chairman & CEO | 1M 0.695% | $2.03 | $2.03M | -0.47% | ||
| 2023-06-08 | Erasca, Inc. ERAS | Chairman & CEO | 100,000 0.0676% | $2.75 | $275,000 | -18.38% | ||
| 2023-03-28 | Erasca, Inc. ERAS | Chairman & CEO | 100,000 0.0693% | $2.84 | $284,000 | -12.41% | ||
| 2023-01-10 | Erasca, Inc. ERAS | Chairman & CEO | 60,000 0.0413% | $3.86 | $231,420 | -29.33% | ||
| 2022-12-14 | Erasca, Inc. ERAS | Chairman & CEO | 40,000 0.0338% | $4.99 | $199,600 | -43.44% | ||
| 2008-03-20 | Sale | Halozyme Therapeutics, Inc. HALO | President, CEO | 250,000 0.2968% | $6.06 | $1.51M | -13.65% | |
| 2007-11-30 | Sale | Halozyme Therapeutics, Inc. HALO | President, CEO | 20,000 0.0261% | $8.24 | $164,796 | -30.9% | |
| 2007-10-31 | Sale | Halozyme Therapeutics, Inc. HALO | President, CEO | 25,000 0.0331% | $9.03 | $225,850 | -31.48% | |
| 2007-09-28 | Sale | Halozyme Therapeutics, Inc. HALO | President, CEO | 25,000 0.033% | $8.78 | $219,524 | -24.17% | |
| 2007-08-31 | Sale | Halozyme Therapeutics, Inc. HALO | President, CEO | 25,000 0.0322% | $8.69 | $217,347 | -25.2% | |
| 2007-07-31 | Sale | Halozyme Therapeutics, Inc. HALO | President, CEO | 20,000 0.0267% | $8.20 | $163,933 | -17.66% | |
| 2007-06-29 | Sale | Halozyme Therapeutics, Inc. HALO | President, CEO | 50,000 0.0701% | $9.49 | $474,456 | -27.84% | |
| 2007-05-31 | Sale | Halozyme Therapeutics, Inc. HALO | President, CEO | 50,000 0.0697% | $10.42 | $521,007 | -26.05% | |
| 2004-08-18 | Halozyme Therapeutics, Inc. HALO | President and CEO | 10,000 0.0253% | $1.61 | $16,100 | +18.01% |